The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells
Abstract Glioblastoma multiforme (GBM) is an extremely aggressive brain tumor, characterized by its high genetic heterogeneity. In search of novel putative therapeutic RNA targets we investigated the role of the oncogenic long noncoding RNA LINC00152 (CYTOR, and STAiR18) in A172 glioblastoma cells....
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f6aa5d7c6fd84bb49a2909a2f8daa5fa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f6aa5d7c6fd84bb49a2909a2f8daa5fa |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f6aa5d7c6fd84bb49a2909a2f8daa5fa2021-12-02T18:02:15ZThe noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells10.1038/s41598-021-97533-82045-2322https://doaj.org/article/f6aa5d7c6fd84bb49a2909a2f8daa5fa2021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97533-8https://doaj.org/toc/2045-2322Abstract Glioblastoma multiforme (GBM) is an extremely aggressive brain tumor, characterized by its high genetic heterogeneity. In search of novel putative therapeutic RNA targets we investigated the role of the oncogenic long noncoding RNA LINC00152 (CYTOR, and STAiR18) in A172 glioblastoma cells. Here, we are the first to describe, that LINC00152 unexpectedly acts in a tumor suppressive manner in this cell line. SiRNA-based knockdown of LINC00152 enhanced malignant tumor behaviors including proliferation, cell cycle entry, migration, and invasion, contradicting previous studies using U87-MG and LN229 glioblastoma cells. Furthermore, LINC00152 knockdown had no influence on survival of A172 glioblastoma cells. In a genome wide transcription analysis of A172 and U87-MG glioblastoma cells, we identified 70 LINC00152 target genes involved in locomotion, cell migration, and motility in A172 cells, whereas in U87-MG cells only 40 target genes were detected. The LINC00152-regulated genes found in A172 differed from those identified in U87-MG glioblastoma cells, none of them being regulated in both cell lines. These findings underline the strong genetic heterogeneity of glioblastoma and point to a potential, yet unknown risk addressing LINC00152 lncRNA as a prospective therapeutic target in GBM.Stefanie BinderIvonne ZipfelClaudia MüllerKarolin WiedemannCarolin SchimmelpfennigGabriele PfeiferKristin ReicheSunna HauschildtJörg LehmannUlrike KöhlFriedemann HornMaik FriedrichNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Stefanie Binder Ivonne Zipfel Claudia Müller Karolin Wiedemann Carolin Schimmelpfennig Gabriele Pfeifer Kristin Reiche Sunna Hauschildt Jörg Lehmann Ulrike Köhl Friedemann Horn Maik Friedrich The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells |
description |
Abstract Glioblastoma multiforme (GBM) is an extremely aggressive brain tumor, characterized by its high genetic heterogeneity. In search of novel putative therapeutic RNA targets we investigated the role of the oncogenic long noncoding RNA LINC00152 (CYTOR, and STAiR18) in A172 glioblastoma cells. Here, we are the first to describe, that LINC00152 unexpectedly acts in a tumor suppressive manner in this cell line. SiRNA-based knockdown of LINC00152 enhanced malignant tumor behaviors including proliferation, cell cycle entry, migration, and invasion, contradicting previous studies using U87-MG and LN229 glioblastoma cells. Furthermore, LINC00152 knockdown had no influence on survival of A172 glioblastoma cells. In a genome wide transcription analysis of A172 and U87-MG glioblastoma cells, we identified 70 LINC00152 target genes involved in locomotion, cell migration, and motility in A172 cells, whereas in U87-MG cells only 40 target genes were detected. The LINC00152-regulated genes found in A172 differed from those identified in U87-MG glioblastoma cells, none of them being regulated in both cell lines. These findings underline the strong genetic heterogeneity of glioblastoma and point to a potential, yet unknown risk addressing LINC00152 lncRNA as a prospective therapeutic target in GBM. |
format |
article |
author |
Stefanie Binder Ivonne Zipfel Claudia Müller Karolin Wiedemann Carolin Schimmelpfennig Gabriele Pfeifer Kristin Reiche Sunna Hauschildt Jörg Lehmann Ulrike Köhl Friedemann Horn Maik Friedrich |
author_facet |
Stefanie Binder Ivonne Zipfel Claudia Müller Karolin Wiedemann Carolin Schimmelpfennig Gabriele Pfeifer Kristin Reiche Sunna Hauschildt Jörg Lehmann Ulrike Köhl Friedemann Horn Maik Friedrich |
author_sort |
Stefanie Binder |
title |
The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells |
title_short |
The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells |
title_full |
The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells |
title_fullStr |
The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells |
title_full_unstemmed |
The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells |
title_sort |
noncoding rna linc00152 conveys contradicting effects in different glioblastoma cells |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/f6aa5d7c6fd84bb49a2909a2f8daa5fa |
work_keys_str_mv |
AT stefaniebinder thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT ivonnezipfel thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT claudiamuller thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT karolinwiedemann thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT carolinschimmelpfennig thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT gabrielepfeifer thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT kristinreiche thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT sunnahauschildt thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT jorglehmann thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT ulrikekohl thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT friedemannhorn thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT maikfriedrich thenoncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT stefaniebinder noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT ivonnezipfel noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT claudiamuller noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT karolinwiedemann noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT carolinschimmelpfennig noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT gabrielepfeifer noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT kristinreiche noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT sunnahauschildt noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT jorglehmann noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT ulrikekohl noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT friedemannhorn noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells AT maikfriedrich noncodingrnalinc00152conveyscontradictingeffectsindifferentglioblastomacells |
_version_ |
1718378963978420224 |